Literature DB >> 9927688

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.

S A Stranford1, J Skurnick, D Louria, D Osmond, S Y Chang, J Sninsky, G Ferrari, K Weinhold, C Lindquist, J A Levy.   

Abstract

Individuals repeatedly exposed to HIV, but who remain uninfected, form a population enriched for persons likely to have either natural or acquired resistance to the virus. We have studied four such exposed uninfected cohorts, representing 60 individuals, for evidence of protective immunity. This population included participants exposed to HIV through anal or vaginal receptive intercourse on multiple occasions over many years. We observed CD8(+)-cell noncytotoxic inhibition of HIV replication in acutely infected CD4(+) cells in the vast majority of individuals most recently exposed to the virus (within 1 year). The levels of this CD8(+)-cell response were sufficient to inhibit the in vitro infection of the exposed subjects' peripheral blood mononuclear cells. We found no evidence of a significant role for CCR5 Delta32 mutation in this population, nor did CD4(+) cell susceptibility to infection or HIV-specific cytotoxic T-lymphocytes correlate with resistance to infection in the individuals tested. Therefore, the observed strong noncytotoxic CD8(+)-cell anti-HIV responses may be an antiviral immune activity contributing to the apparent protection from infection in these exposed uninfected individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927688      PMCID: PMC15345          DOI: 10.1073/pnas.96.3.1030

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual.

Authors:  C E Mackewicz; H W Ortega; J A Levy
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

Review 2.  Protective immunity against HIV infection: has nature done the experiment for us?

Authors:  G M Shearer; M Clerici
Journal:  Immunol Today       Date:  1996-01

Review 3.  HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation.

Authors:  M J McElrath; R F Siliciano; K J Weinhold
Journal:  AIDS Res Hum Retroviruses       Date:  1997-02-10       Impact factor: 2.205

4.  An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status.

Authors:  A L Landay; C E Mackewicz; J A Levy
Journal:  Clin Immunol Immunopathol       Date:  1993-10

5.  T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques.

Authors:  M Clerici; E A Clark; P Polacino; I Axberg; L Kuller; N I Casey; W R Morton; G M Shearer; R E Benveniste
Journal:  AIDS       Date:  1994-10       Impact factor: 4.177

6.  IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).

Authors:  G Ferrari; K King; K Rathbun; C A Place; M V Packard; J A Bartlett; D P Bolognesi; K J Weinhold
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners.

Authors:  A Ranki; S Mattinen; R Yarchoan; S Broder; J Ghrayeb; J Lähdevirta; K Krohn
Journal:  AIDS       Date:  1989-02       Impact factor: 4.177

8.  Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.

Authors:  P Langlade-Demoyen; N Ngo-Giang-Huong; F Ferchal; E Oksenhendler
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

10.  CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor.

Authors:  J E Brinchmann; G Gaudernack; F Vartdal
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

View more
  39 in total

Review 1.  New approaches to design HIV-1 T-cell vaccines.

Authors:  Hélène Perrin; Glenda Canderan; Rafick-Pierre Sékaly; Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

Review 2.  Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals.

Authors:  Barbara L Shacklett
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

Review 3.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

4.  Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level.

Authors:  A L Erickson; C B Willberg; V McMahan; A Liu; S P Buchbinder; L A Grohskopf; R M Grant; D F Nixon
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

Review 5.  The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

Authors:  Myron S Cohen; Nick Hellmann; Jay A Levy; Kevin DeCock; Joep Lange
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  Discovery of another anti-HIV protein in the search for the CD8+ cell anti-HIV Factor.

Authors:  Jay A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-17       Impact factor: 11.205

7.  Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication.

Authors:  I S Choi; R Hokanson; E W Collisson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.

Authors:  Suresh Pallikkuth; Ajay Wanchu; Archana Bhatnagar; Ravinder Kaur Sachdeva; Meera Sharma
Journal:  Clin Vaccine Immunol       Date:  2007-09

9.  Functional characterization of human Tc0, Tc1 and Tc2 CD8+ T cell clones: control of X4 and R5 HIV strain replication.

Authors:  Michèle Février; Sylvie le Borgne; Christian Marty; Antoine Talarmin; Yves Rivière
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

10.  Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review.

Authors:  Ramachandran Meenakshisundaram; Shah Sweni; Ponniah Thirumalaikolundusubramanian
Journal:  AIDS Res Ther       Date:  2009-11-19       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.